Vance Street Portfolio Firms Integrated Into One Unit

Owners of medical component suppliers can now access unified engineering and commercial resources from one organization.

Updated on Sept. 22, 2026 in Business Strategy

Isometric editorial illustration of medical valves and tubing components arranged precisely on a neutral surface.
Vance Street Capital has integrated three medical component suppliers—MRPC, Plastic Design Company, and Injectech—into a single operational organization. AI Illustration. Upload story photo >

Live Poll

Do you prefer working with a single consolidated supplier for complex manufacturing needs?

Vance Street Capital has completed the operational integration of MRPC, Plastic Design Company, and Injectech into a single entity. The combined organization maintains five manufacturing sites across the United States.

Why it matters

The merger aims to provide customers with streamlined access to fluid management and component manufacturing capabilities that previously required coordinating with multiple suppliers. This shift allows the firm to consolidate its engineering and commercial operations to better compete for integrated project contracts.

The integration combines 3 core businesses that operate 5 manufacturing sites under the new management of CEO Greg Riemer, who brings 30+ years of industry experience to the role.

The players

Vance Street Capital

A private equity firm that manages and grows industrial and medical technology portfolios through targeted acquisitions.

Greg Riemer

The newly appointed CEO of the combined organization who has over 30 years of industry experience and previously served as president of MRPC.

MRPC

A specialized manufacturer of medical components and one of the three core companies integrated into the new organization.

Injectech

A provider of catalog and custom fluid management components now operating as part of the unified entity.

The details

The firm has synchronized leadership teams, engineering resources, and commercial operations to create a single point of service for its client base. While the businesses will retain their individual names until a brand transition occurs in 2027, they are now coordinating sales and service pipelines. This restructuring reduces the friction of cross-departmental communication, allowing the organization to offer a broader suite of catalog and custom fluid management components under one operational umbrella.

Timeline

  1. Greg Riemer became president of MRPC in 2010.

  2. Vance Street Capital acquired the three businesses between 2021 and 2025.

  3. Plastic Design Company acquired Resenex in 2024.

  4. The organization announced its integrated operations on September 22, 2026.

  5. The entities will exhibit together at MD&M Midwest on October 28-29, 2026.

Market Landscape

This integration follows the established pattern of private equity firms consolidating niche medical manufacturing players to achieve economies of scale. It represents a shift from independent, specialized operations to a unified commercial model within the broader medical component sector.

Operators currently sourcing from these suppliers should evaluate how the new single-point commercial structure affects their procurement contracts. Assess whether the transition simplifies supply chain management or warrants a review of current pricing and service-level agreements.

The takeaway

Operational integration offers businesses a path to reduce supply chain complexity by centralizing vendor relationships and technical resources. Track the upcoming 2027 brand transition to determine how this organizational change impacts future contract renewals and product availability.

What happens next

The combined company will introduce a unified brand identity in early 2027.

Further reading

For more on industry consolidation trends, visit the Business Strategy section.

Live Poll

Do you prefer working with a single consolidated supplier for complex manufacturing needs?